Additional low-dose Rivaroxaban lowers the Mortality in Patients with CHD or PAOD

被引：0
|
作者：
Lichert, Frank
机构：
来源：
AKTUELLE KARDIOLOGIE | 2021年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [41] RENAL SUPPORT IN CRITICALLY ILL PATIENTS - LOW-DOSE DOPAMINE OR LOW-DOSE DOBUTAMINE
    DUKE, GJ
    BRIEDIS, JH
    WEAVER, RA
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (12) : 1919 - 1925
  • [42] Letter by Xiang and Cui Regarding Article, "Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation"
    Xiang, Qian
    Cui, Yimin
    [J]. STROKE, 2020, 51 (01) : E9 - E9
  • [43] Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: A randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate
    Zikos, P
    Van Lint, MT
    Frassoni, F
    Lamparelli, T
    Gualandi, F
    Occhini, D
    Mordini, N
    Berisso, G
    Bregante, S
    De Stefano, F
    Soracco, M
    Vitale, V
    Bacigalupo, A
    [J]. BLOOD, 1998, 91 (09) : 3503 - 3508
  • [44] Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial
    Opstal, Tjerk S. J.
    Nidorf, Stefan M.
    Fiolet, Aernoud T. L.
    Eikelboom, John W.
    Mosterd, Arend
    Bax, Willem A.
    Budgeon, Charley A.
    Ronner, Eelko
    Prins, Fransisco J.
    Tijssen, Jan G. P.
    Schut, Astrid
    Thompson, Peter L.
    El Messaoudi, Saloua
    Cornel, Jan H.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 372 : 1 - 5
  • [45] LOW-DOSE ASPIRIN AND MORTALITY IN PATIENTS WITH CORONAVIRUS DISEASE 2019: A META-ANALYSIS
    Beran, Azizullah
    Mhanna, Mohammed
    Srour, Omar
    Ayesh, Hazem
    Khokher, Waleed
    Malhas, Saif-Eddin
    Abuhelwa, Ziad
    Alsaiqali, Mahmoud
    Eltahawy, Ehab Ahmed
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2060 - 2060
  • [46] Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients
    Tagami, Takashi
    Matsui, Hiroki
    Horiguchi, Hiromasa
    Fushimi, Kiyohide
    Yasunaga, Hideo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (02) : 463 - 472
  • [47] LOW-DOSE COMBINATION ANTIHYPERTENSIVE THERAPY - ADDITIONAL EFFICACY WITHOUT ADDITIONAL ADVERSE-EFFECTS
    MACCONNACHIE, AM
    MACLEAN, D
    [J]. DRUG SAFETY, 1995, 12 (02) : 85 - 90
  • [48] Low-dose apixaban or rivaroxaban as secondary prophylaxis of upper extremity deep vein thrombosis
    Ligia, S.
    Musiu, P.
    Serrao, A.
    Santoro, C.
    Taglietti, A.
    Capriata, M.
    Faccini, A.
    Molinari, M. C.
    Baldacci, E.
    Chistolini, Antonio
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (02) : 323 - 326
  • [49] SUITABILITY FOR LOW-DOSE RIVAROXABAN BASED ON COMPASS TRIAL: A DISTRICT GENERAL HOSPITAL PERSPECTIVE
    Asad, Muhammad
    Kazi, Sayed Irfan
    Gupta, Mehak
    Alaguraja, Priyanth
    McCaughey, Daniel
    Makan, Jayesh
    [J]. HEART, 2021, 107 : A155 - A155
  • [50] ADDITIONAL DEGRADANTS IN THE IMPURITY PROFILE OF ATROPINE LOW-DOSE OPHTHALMIC SOLUTION
    Cebulska, Ewelina
    Malik, Katarzyna
    Czarnecka, Kamila
    Szymanski, Pawel
    [J]. ACTA POLONIAE PHARMACEUTICA, 2023, 80 (04): : 541 - 550
12345